Search Results - mhcii

1 Results Sort By:
HIV-1 Therapeutic Inhibits Viral Entry
Abstract: Soluble forms (sCD4) of human CD4, the HIV-1 primary receptor, are potent HIV-1 entry inhibitors. Both four-domain (D1-4) and two-domain (D1D2) sCD4 and their fusion proteins have been tested as candidate therapeutics in animal models and in human clinical trials and were well tolerated by patients with no significant clinical or immunologic...
Published: 5/22/2024   |   Inventor(s): Dimiter Dimitrov, Weizhao Chen, Prabakaran Ponraj
Keywords(s): CD4, entry inhibitor, HIV, MHCII, soluble expression
Category(s): Application > Therapeutics, TherapeuticArea > Infectious Disease, Collaboration Sought > Licensing, TherapeuticArea > Oncology